Clinical Trials
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO) drug...
Drug Research
Coronavirus Drug Development Update from NanoViricides, Inc
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its efforts...
Press Releases
EC approves Alnylams Givlaari for acute hepatic porphyria
The European Commission (EC) has approved Alnylam’s Givlaari (givosiran) for adults and adolescents with acute hepatic porphyria (AHP).
Givlaari was previously granted priority medicines designation by...
IT & Data Management
Predictive oncology to launch AI drug discovery platform for Covid-19
Predictive Oncology has announced plans to launch an artificial intelligence (AI) technology platform for vaccine and drug development under an operating agreement with Soluble Therapeutics.
The...
Press Releases
Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil
Hospital PUC-Campinas Celso Pierro joins the global hospital network on Patient Network Explorer, bringing its patients access to leading-edge medical interventions via international, sponsored clinical...
Press Releases
Turkish Cargo wins the Fastest Growing International Cargo Airline of the Year award
Maintaining its successful growth, Turkish Cargo was announced as the winner of the ‘‘Fastest Growing International Cargo Airline of the Year” award at the Air...
Press Releases
Turkish Cargo adds Quito the capital of Ecuador to its cargo flight network
Turkish Cargo, the fastest growing global air cargo carrier, continues to expand its flight network. The successful air cargo brand has just added Quito (UIO),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.